Portfolio intelligence for authorised representatives
When an authorised representative manages multiple manufacturers, the operational challenge is often not one registration. It is keeping portfolio evidence, transition questions and unresolved dependencies visible across many client relationships.
ClinicOps provides a partner-friendly evidence and prioritisation layer that can sit beside existing representation and registration services.
What the partner layer does
- normalises portfolio intake into a consistent review shape;
- separates manufacturer, AR, importer and system/procedure-pack context;
- surfaces missing or contradictory evidence before review begins;
- organises transition and document-operation questions into a work queue;
- returns Markdown and machine-readable JSON handoffs where useful;
- keeps human regulatory judgement explicit.
What it does not do
ClinicOps is not positioned as a replacement for the authorised representative relationship, a notified body or the manufacturer's RA/QA function. The value is in reducing repeated manual reconciliation and making portfolio-scale evidence easier to review, hand off and revisit.
White-label / partner use
The operating model can support one-off portfolio pilots, white-label evidence reconciliation, recurring transition work-plan updates, and structured handoffs into an existing consultancy or AR workflow. Client-specific regulatory conclusions remain human-reviewed and within the responsible party's process.
Pilot shape
Start with one supplied portfolio export. ClinicOps can return intake diagnostics, role-aware segmentation, a prioritised operational queue, an evidence-gap ledger, and a human-review handoff.